Cine MR Imaging of Myocardial Contractile Impairment in Patients with Hypertrophic Cardiomyopathy Attributable to Asp175Asn Mutation in the α-Tropomyosin Gene
Authors:
- Kirsi LauermaKLKirsi Lauerma
- Pertti JääskeläinenPJPertti Jääskeläinen
- Markku LaaksoMLMarkku Laakso
- Keijo PeuhkurinenKPKeijo Peuhkurinen
- Hannu ManninenHMHannu Manninen
- Hannu J. AronenHAHannu J. Aronen
- Johanna KuusistoJKJohanna Kuusisto
- 1 September 2005
- journal article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 236 (3) , 815-824
Abstract
To prospectively investigate the relationship between myocardial contractile impairment and left ventricular (LV) hypertrophy measured at cardiac magnetic resonance (MR) imaging in patients with hypertrophic cardiomyopathy (HCM) caused by the substitution of aspartic acid 175 with asparagine (ie, Asp175Asn mutation) in the alpha-tropomyosin gene (TPM1). The study protocol was approved by the hospital ethics committee, and all subjects gave written informed consent. LV mass, maximal LV wall thickness, and myocardial fractional thickening during systole were measured at cine MR imaging in 24 subjects (11 male, 13 female; mean age, 42 years; age range, 17-68 years) with the Asp175Asn mutation in TPM1 and in 17 healthy volunteers (eight men, nine women; mean age, 38 years; age range, 23-60 years). The proportion of hypokinetic LV segments was calculated as the number of LV segments with fractional thickening of less than 30% divided by the total number of segments measured. Anthropometric and biochemical correlates of LV hypertrophy were determined. Univariate and multiple linear regression analyses were used to investigate the association of the proportion of hypokinetic segments and other correlates of LV hypertrophy with LV mass and maximal wall thickness. The proportion of hypokinetic segments was higher in patients with HCM than in control subjects (37% +/- 20 [standard deviation] vs 12% +/- 12, P < .001). In stepwise multiple regression analysis, the proportion of hypokinetic segments accounted for 42% (P < .001); the LV end-diastolic volume, for 24% (P = .003); and male sex, for 10% (P = .014) of the variability in LV mass in patients with HCM. The proportion of hypokinetic LV segments, which accounted for 48% of the variability in LV maximal wall thickness (P < .001), was the only variable significantly associated with maximal wall thickness. The extent of myocardial contractile impairment is strongly and independently related to LV mass and maximal wall thickness in patients with HCM attributable to the Asp175Asn mutation in TPM1.Keywords
This publication has 49 references indexed in Scilit:
- Phenotypic diversity in hypertrophic cardiomyopathyHuman Molecular Genetics, 2002
- Genetic polymorphisms in the renin-angiotensin-aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C geneHeart, 2002
- The Influence of the Angiotensin I Converting Enzyme Genotype in Familial Hypertrophic Cardiomyopathy Varies with the Disease Gene MutationJournal of Molecular and Cellular Cardiology, 1997
- Assessment of quantitative hypertrophy scores in hypertrophic cardiomyopathy: Magnetic resonance imaging versus echocardiographyAmerican Heart Journal, 1996
- Angiotensin-I Converting Enzyme Genotypes and Left Ventricular Hypertrophy in Patients With Hypertrophic CardiomyopathyCirculation, 1995
- Left ventricular wall thickness and regional systolic function in patients with hypertrophic cardiomyopathy. A three-dimensional tagged magnetic resonance imaging study.Circulation, 1994
- Three-dimensional left ventricular deformation in hypertrophic cardiomyopathy.Circulation, 1994
- Measurement of left ventricular mass in hypertrophic cardiomyopathy using MRI: Comparison with echocardiographyMagnetic Resonance Imaging, 1993
- MR imaging of hypertrophic cardiomyopathy.Radiology, 1992
- Magnetic resonance imaging in hypertrophic cardiomyopathyThe American Journal of Cardiology, 1985